Submit Deal

Announced

1 Oct 2018

Completed

8 Nov 2018

Bain Capital and Cinven completed the acquisition of a 28% stake in STADA Arzneimittel for 1.5bn.

Synopsis

Bain Capital, an American private investment firm, and Cinven, a global private equity firm, completed the acquisition of a 28% stake in STADA Arzneimittel, a pharmaceutical company, for £1.5bn.

Principals

target

Stada Arzneimittel

bidder

Bain Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

mark keatley

CFO at STADA ARZNEIMITTEL AG

Manager

target

Deals

£ 4.45 B

Total Value

miguel pagan fernandez

Chief Technology Officer at STADA ARZNEIMITTEL AG

Manager

target

Deals

£ 4.45 B

Total Value

peter goldschmidt

Chairman and CEO at STADA ARZNEIMITTEL AG

Manager

target

Deals

£ 4.96 B

Total Value

Bidder Team (9)

daniel borg

Partner at Kirkland & Ellis

Lawyer

bidder

Deals

£ 49.22 B

Total Value

mark aschenbrenner

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 24.93 B

Total Value

sebastian häfele

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 31.79 B

Total Value

maximilian heufelder

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 7.27 B

Total Value

daniel hiemer

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 22.96 B

Total Value

katharina hohmann

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 8.56 B

Total Value

thomas krawitz

Kirkland & Ellis

Lawyer

bidder

Deals

£ 8.56 B

Total Value

edward gascoigne-pees

Partner at Camarco

PR Consultant

bidder

Deals

£ 22.55 B

Total Value

alexander langsfeld

Associate at Kirkland & Ellis

Lawyer

bidder

Deals

£ 14.13 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy